Operating Income (Loss) in USD of Praxis Precision Medicines, Inc. from Q3 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Praxis Precision Medicines, Inc. quarterly/annual Operating Income (Loss) history and change rate from Q3 2019 to Q3 2025.
  • Praxis Precision Medicines, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$78.4M, a 37.9% decline year-over-year.
  • Praxis Precision Medicines, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$293M, a 78.7% decline year-over-year.
  • Praxis Precision Medicines, Inc. annual Operating Income (Loss) for 2024 was -$200M, a 58.4% decline from 2023.
  • Praxis Precision Medicines, Inc. annual Operating Income (Loss) for 2023 was -$126M, a 41.2% increase from 2022.
  • Praxis Precision Medicines, Inc. annual Operating Income (Loss) for 2022 was -$215M, a 28.5% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

Praxis Precision Medicines, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$293M -$78.4M -$21.5M -37.9% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 -$272M -$76.1M -$38.6M -103% 01 Apr 2025 30 Jun 2025 10-Q 04 Aug 2025
Q1 2025 -$233M -$74.7M -$32.8M -78.4% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025
Q4 2024 -$200M -$64M -$36.2M -130% 01 Oct 2024 31 Dec 2024 10-K 28 Feb 2025
Q3 2024 -$164M -$56.8M -$31.3M -123% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025
Q2 2024 -$133M -$37.5M -$2.53M -7.23% 01 Apr 2024 30 Jun 2024 10-Q 04 Aug 2025
Q1 2024 -$130M -$41.9M -$3.8M -9.96% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025
Q4 2023 -$126M -$27.8M +$13.6M +32.9% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025
Q3 2023 -$140M -$25.5M +$18.8M +42.4% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 -$159M -$35M +$25.4M +42.1% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 -$184M -$38.1M +$30.8M +44.7% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 -$215M -$41.5M +$17.2M +29.3% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 -$232M -$44.3M +$483K +1.08% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 -$233M -$60.4M -$23.9M -65.5% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 -$209M -$68.8M -$41.4M -151% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 -$167M -$58.7M -$32.9M -128% 01 Oct 2021 31 Dec 2021 10-K 07 Feb 2023
Q3 2021 -$134M -$44.8M -$28.6M -176% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$106M -$36.5M -$24.9M -215% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$80.9M -$27.4M -$19M -224% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$62M -$25.7M 01 Oct 2020 31 Dec 2020 10-K 28 Feb 2022
Q3 2020 -$16.2M -$5.56M -52.2% 01 Jul 2020 30 Sep 2020 10-Q 03 Nov 2021
Q2 2020 -$11.6M 01 Apr 2020 30 Jun 2020 10-Q 16 Aug 2021
Q1 2020 -$8.47M 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q3 2019 -$10.7M 01 Jul 2019 30 Sep 2019 10-Q 23 Nov 2020

Praxis Precision Medicines, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$200M -$73.8M -58.4% 01 Jan 2024 31 Dec 2024 10-K 28 Feb 2025
2023 -$126M +$88.6M +41.2% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025
2022 -$215M -$47.7M -28.5% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 -$167M -$105M -170% 01 Jan 2021 31 Dec 2021 10-K 07 Feb 2023
2020 -$62M -$26.2M -73.1% 01 Jan 2020 31 Dec 2020 10-K 28 Feb 2022
2019 -$35.8M 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.